跳至主要内容
临床试验/NCT02567487
NCT02567487Unknown4 期

Comparison of TAP Block With Two Different Doses of Levobupivacaine for Postoperative Pain Management in Pediatric Patients

Ankara University0 个研究点目标入组 50 人开始时间: 2015年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
50
主要终点
postoperative VAS score <4 at postoperative 24 hours

研究概览

简要总结

The aim of the current study is to investigate the effects of two different doses of levobupivacaine in TAP (transversus abdominus plane) block for postoperative management. For this purpose we planned to include 50 children aged between 2 and 12 that will undergo unilateral inguinal surgery.

The doses that will be used in the study were within usual dose limits which is stated in prospectus of the study drug.

详细描述

Fifty children undergoing TAP block were randomly divided into two groups as levobupivacaine 0.25% 0.5 ml/kg and levobupivacaine 0.25% 0.25 ml/kg. Postoperative pain was evaluated with observational pain scale and modified pediatric objective pain scale.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
2 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Volunteers planned to undergo unilateral inguinal surgery under TAP (ilioinguinal and iliohypogastric block) and general anesthesia
  • Aged between 2 and 12

排除标准

  • Patients with coagulation dysfunction
  • Patients with chronic pain
  • Patients having infection at the site of intervention
  • Patients with a history of allergy
  • Patients having chronic diseases (hepatic dysfunction, renal failure)

研究组 & 干预措施

Group Levobupivacaine high volume

Active Comparator

TAP block with levobupivacaine 0.25% of 0.5 ml/kg under general anesthesia

干预措施: Levobupivacaine (Drug)

Group Levobupivacaine low volume

Active Comparator

TAP block with levobupivacaine 0.25% of 0.25 ml/kg under general anesthesia

干预措施: Levobupivacaine (Drug)

结局指标

主要结局

postoperative VAS score <4 at postoperative 24 hours

时间窗: Postoperative first 24 hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Emel Uyar

Doctor

Ankara University

相似试验

TAP Block With Two Different Doses of Levobupivacaine | 临床试验